Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Study Type: Treatment
Phase: II
NCTID: NCT03919071
Principal Investigator:
Keith August
Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
Study Type: Other
Phase: N/A
NCTID: NCT01793233
Principal Investigator:
Keith August
A Phase II Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway?Mutant Acute Lymphoblastic Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT02723994
Principal Investigator:
Kevin Ginn
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial ALCHEMIST
Phase II Trial of Intravesical Gemcitabine and MK-3475 Pembrolizumab in the Treatment of Patients with BCGUnresponsive Non-Muscle Invasive Bladder Cancer
A Phase I Dose Escalation and Expanded Cohort Study of Pf-06821497 in the Treatment of Adult Patients with Relapsed/Refractory Small Cell Lung Cancer SCLC, Castration Resistant Prostate Cancer CRPC and Follicular Lymphoma FL
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Study Type: Treatment
Phase: I
NCTID: NCT02303821
Principal Investigator:
Kevin Ginn